Author

Mohammed A. Khan

Queen Mary University of LondonORCID 0000-0001-9473-8679Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Mohammed A. Khan2 papers · University of Chicago

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Ann‐Marie BakeriD· 1 shared Eszter LakatosiD· 1 shared Francesco Nicolini· 1 shared Helen HockingsiD· 1 shared Kane SmithiD· 1 shared Maximilian MossneriD· 1 shared Michelle LockleyiD· 1 shared Stephen Metcalf· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ann‐Marie BakerORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCancer ResearchPeer-reviewedApr 29, 2025

Adaptive therapy achieves long-term control of chemotherapy resistance in high grade ovarian cancer

Helen Hockings, Eszter Lakatos, Weini Huang…·Michelle Lockley

This study demonstrates that adaptive therapy reduces chemotherapy resistance in ovarian cancer by exploiting fitness costs of resistant cells, extending survival in mice and correlating with disease burden in patients.

42 citationstop 1%

𝕏 PostBluesky